CH652307A5 - Pharmazeutische zusammensetzung fuer die orale anwendung. - Google Patents

Pharmazeutische zusammensetzung fuer die orale anwendung. Download PDF

Info

Publication number
CH652307A5
CH652307A5 CH4123/82A CH412382A CH652307A5 CH 652307 A5 CH652307 A5 CH 652307A5 CH 4123/82 A CH4123/82 A CH 4123/82A CH 412382 A CH412382 A CH 412382A CH 652307 A5 CH652307 A5 CH 652307A5
Authority
CH
Switzerland
Prior art keywords
tocopherolphenolate
oil
composition according
drug
unsaturated fatty
Prior art date
Application number
CH4123/82A
Other languages
German (de)
English (en)
Inventor
Shimesu Motoyama
Satoshi Sato
Seiichi Umeda
Hirotsune Yasumi
Emiko Sudo
Takuichi Tsujino
Akira Akazawa
Original Assignee
Freunt Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10977781A external-priority patent/JPS5813508A/ja
Priority claimed from JP17516881A external-priority patent/JPS5877810A/ja
Application filed by Freunt Ind Co Ltd filed Critical Freunt Ind Co Ltd
Publication of CH652307A5 publication Critical patent/CH652307A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH4123/82A 1981-07-14 1982-07-06 Pharmazeutische zusammensetzung fuer die orale anwendung. CH652307A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10977781A JPS5813508A (ja) 1981-07-14 1981-07-14 ポリグリセロール飽和脂肪酸エステルを含む経口薬剤組成物
JP17516881A JPS5877810A (ja) 1981-11-01 1981-11-01 ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物

Publications (1)

Publication Number Publication Date
CH652307A5 true CH652307A5 (de) 1985-11-15

Family

ID=26449492

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4123/82A CH652307A5 (de) 1981-07-14 1982-07-06 Pharmazeutische zusammensetzung fuer die orale anwendung.

Country Status (4)

Country Link
US (1) US4751241A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880000970B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH652307A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3224619A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3588023D1 (de) * 1984-01-28 1995-06-29 Roshdy Ismail Mittel zur Behandlung von Herzerkrankungen.
US5656620A (en) * 1984-01-28 1997-08-12 Ismail; Roshdy Method for treating pain
US5229164A (en) * 1985-12-19 1993-07-20 Capsoid Pharma Gmbh Process for producing individually dosed administration forms
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
JP2643217B2 (ja) * 1988-01-22 1997-08-20 エーザイ株式会社 脂溶性物質水性液
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
AU645003B2 (en) * 1988-11-08 1994-01-06 Takeda Chemical Industries Ltd. Sustained release preparations
JPH02188523A (ja) * 1989-01-13 1990-07-24 M S C:Kk 睡眠時無呼吸症治療薬
DK0484529T3 (da) * 1989-08-03 1994-05-30 Hisamitsu Pharmaceutical Co Hudcremepræparat til udvortes brug
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
US5179122A (en) * 1991-02-11 1993-01-12 Eastman Kodak Company Nutritional supplement containing vitamin e
DE69324523T2 (de) * 1992-06-12 1999-09-09 Kao Corp. Badezusatzzusammensetzung enthaltend oberflächenaktive Mittel enthaltende nahtlose Kapsel und Verfahren zur Herrstellung der Kapsel
IT1256386B (it) * 1992-11-13 1995-12-04 Luigi Boltri Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo
AU5832794A (en) * 1993-01-06 1994-08-15 T.S. Consult Aps Medium comprising a pharmacological/biological active substance
DE19647352C2 (de) * 1996-11-15 2000-06-29 Aqua Nova Getraenketechnologie Nicht alkoholisches Getränk mit einem Gehalt an Q 10
DE19722405A1 (de) * 1997-05-28 1998-12-03 Ifac Inst Fuer Angewandte Coll Einkapseln von wasserunlöslichen Wirkstoffen mit amphiphilem Charakter
WO1999022719A1 (fr) * 1997-10-30 1999-05-14 Morishita Jintan Co., Ltd. Preparation de capsule contenant un acide gras insature ou un derive de celui-ci, et procede de fabrication
ATE462417T1 (de) 1998-08-13 2010-04-15 Cima Labs Inc Microemulsionen als feste dosisformen zur oralen verabreichung
IT1304406B1 (it) * 1998-10-21 2001-03-19 Danital Italia S R L Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
AP2002002552A0 (en) 1999-12-23 2002-06-30 Pfizer Prod Inc Pharmaceutical compositions providing enhanced drug concentrations.
US6692771B2 (en) 2001-02-23 2004-02-17 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
DE10133305B4 (de) * 2001-07-12 2004-06-03 Aquanova German Solubilisate Technologies (Agt) Gmbh Ubichinon Konzentrat
JP3549197B2 (ja) * 2001-08-10 2004-08-04 日清ファルマ株式会社 ユビキノン含有製剤
TW200302056A (en) * 2002-01-18 2003-08-01 Kaneka Corp Method for stabilizing reduced coenzyme Q10 and composition therefor
WO2004064543A1 (ja) * 2003-01-17 2004-08-05 Taiyo Kagaku Co., Ltd. コエンザイムq10含有組成物
ES2496102T3 (es) * 2003-03-28 2014-09-18 Sigmoid Pharma Limited Forma de dosificación oral sólida que contiene microcápsulas sin fisuras
ES2401185T3 (es) * 2004-09-27 2013-04-17 Sigmoid Pharma Limited Formulaciones de microcápsulas que comprenden dos ingredientes farmacéuticamente activos
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
JP5399072B2 (ja) 2005-09-12 2014-01-29 アベラ ファーマスーティカルズ インコーポレイテッド ジメチルスルホキシド（ｄｍｓｏ）若しくは関連化合物、又はそれに関連する臭気を除去するシステム
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
US9427419B2 (en) 2005-09-12 2016-08-30 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (DMSO)
US8506956B2 (en) * 2005-10-31 2013-08-13 Kaneka Corporation Method for stabilizing reduced coenzyme Q10
JP5128801B2 (ja) * 2006-10-16 2013-01-23 フロイント産業株式会社 高水分散性粉末とその製造方法
US8911777B2 (en) * 2007-04-04 2014-12-16 Sigmoid Pharma Limited Pharmaceutical composition of tacrolimus
CA2685118C (en) * 2007-04-26 2016-11-01 Sigmoid Pharma Limited Manufacture of multiple minicapsules
WO2008132712A2 (en) * 2007-05-01 2008-11-06 Sigmoid Pharma Limited Combination pharmaceutical compositions
EP2172223B1 (en) * 2007-06-22 2020-12-16 Kaneka Corporation Composition containing physiologically active substance
US20110123505A1 (en) * 2007-08-22 2011-05-26 Kaneka Corporation Method of producing reduced coenzyme q10 and method of stabilizing the same
WO2009025372A1 (ja) * 2007-08-23 2009-02-26 Kaneka Corporation 還元型補酵素ｑ１０含有組成物及びその安定化方法
BRPI0921494A2 (pt) * 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
GB2483815B (en) 2009-05-18 2013-12-25 Sigmoid Pharma Ltd Composition comprising oil drops
IN2012DN00781A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2009-08-12 2015-06-26 Sigmoid Pharma Ltd
EP2493314B1 (en) 2009-10-30 2020-04-08 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
AU2015217651A1 (en) * 2014-02-13 2016-09-01 Clariant International Ltd. Preparation of polyglycerols
HUE053624T2 (hu) 2014-11-07 2021-07-28 Sublimity Therapeutics Ltd Ciklosporint tartalmazó készítmények
JP7560982B2 (ja) * 2020-09-18 2024-10-03 日清ファルマ株式会社 コエンザイムｑ１０含有水溶性組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations
US3966632A (en) * 1974-06-06 1976-06-29 G. D. Searle & Co. Vegetable oil emulsion
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
JPS574916A (en) * 1980-05-28 1982-01-11 Furointo Sangyo Kk Activation of medical preparation
US4327076A (en) * 1980-11-17 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same

Also Published As

Publication number Publication date
KR840000233A (ko) 1984-02-18
US4751241A (en) 1988-06-14
KR880000970B1 (ko) 1988-06-07
DE3224619A1 (de) 1983-05-19
DE3224619C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-10-04

Similar Documents

Publication Publication Date Title
CH652307A5 (de) Pharmazeutische zusammensetzung fuer die orale anwendung.
DE69526655T2 (de) Wässrige emulsion mit kontrollierter freisetzung
EP0178436B1 (de) Ibuprofen enthaltende Weichgelatinekapseln und Verfahren zu ihrer Herstellung
DE3853191T2 (de) Arzneimittelträger.
EP0277459B1 (de) Arzneimittel mit verzögerter Wirkstofffreisetzung
DE69422861T2 (de) Pharmazeutische Zusammensetzung mit kontrollierter Freigabe auf Grund von einer oder mehrerer pharmazeutischer verträglicher Salze von Gamma-Hydroxybuttersäure
DE69733966T2 (de) Feste lipidzusammensetzungen von lipophilen verbindungen zur verbesserten oralen bioverfügbarkeit
DE68914929T2 (de) Emulgierte Zusammensetzung.
DE69524953T2 (de) Antibakterielle öl-in-wasser-emulsion
DE69429928T2 (de) Zweiphasige zusammensetzung in kapselnform
DE3013839A1 (de) Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
DE60018372T2 (de) Oralzusammensetzung als mikroemulsion von silybin
EP3908253B1 (de) Oraler dünnfilm
DE69133042T2 (de) Lyophilisierte zubereitung sowie deren herstellung
DE69324214T2 (de) Pharmazeutische flüssige Suspensionszusammensetzung mit kontrollierter Freigabe
WO2001091729A1 (de) Formulierung auf heparin-, glycosaminoglykan- oder heparinoidbasis und verwendung der formulierung sowie der formulierungsgrundlage
DE69921919T2 (de) Sterolester in tablettierter fester Arzneiform
JPH0474339B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP1249230B1 (de) Coenzym Q10 enthaltende Mikroemulsion-Prekonzentrate und Mikroemulsionen
DE69100436T2 (de) Kalzitonin enthaltende Emulsion zur nasalen Verabreichung.
EP0461290B1 (de) Flüssig befüllte Steckkapselpräparate
DE69001682T2 (de) Wasserdisperierbare gemfibrozilhaltige mittel.
DE4038385C2 (de) Sitosterol und seine Glykoside mit verbesserter Bioverfügbarkeit
EP1249231B1 (de) Pharmazeutische Formulierungen enthaltend entzündungshemmende Wirkstoffe und deren Verwendung
DE60006000T2 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung

Legal Events

Date Code Title Description
PL Patent ceased